Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about SANOFI
08:25aSANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
GL
08:25aLate-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy incre..
GL
09/20SANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
GL
09/20SANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
AQ
09/20SANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
AQ
09/20Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy incre..
GL
09/18SANOFI : and GSK confirm agreement with European Union to supply up to 300 milli..
AQ
09/18EU Agrees to Buy Potential Sanofi, GSK Covid-19 Vaccine -- Update
DJ
09/18SANOFI : and GSK will provide up to 300 million doses of COVID-19 vaccine to the..
PU
09/18EU Agrees to Buy Potential Sanofi, GSK Covid-19 Vaccine
DJ
09/18SANOFI : Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally ..
AQ
09/18SANOFI : Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally ..
AQ
09/18SANOFI : Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally ..
GL
09/18Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally advanc..
GL
09/18SANOFI : Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corp..
AQ
More most relevant news
All news about SANOFI
08:25aSANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
GL
08:25aLate-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy incre..
GL
07:33aEXCLUSIVE : EU in early talks with Italy's ReiThera over potential vaccine suppl..
RE
07:21aEU in early talks with Italy's ReiThera over potential vaccine supply deal -s..
RE
09/20SANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
GL
09/20SANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
AQ
09/20SANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
AQ
09/20Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy incre..
GL
09/18When will COVID-19 vaccines be generally available in the U.S.?
RE
09/18NEWS HIGHLIGHTS : Top Company News of the Day
DJ
More news
News in other languages on SANOFI
10:48aCAC40 : la correction se transforme en sell-off, -3% à WStreet
09:29aCAC40 : pire entame de 4ème trimestre depuis 2011, banques -5%
08:25aSANOFI : Une présentation de dernière minute au congrès de l'ESMO montre qu'une ..
05:11aCAC40 : chute de 2,7% dans le sillage de Wall Street
03:08aLes valeurs à suivre aujourd'hui à la Bourse de Paris Lundi 21 septembre 2020
03:01aQuand la banque européenne s'éveillera...
02:50aSANOFI : présentation de dernière minute encourageante dans le cancer du poumon
02:22aEN DIRECT DES MARCHES : Société Générale, Airbus, LVMH, Iliad, Orpea, Vallourec,..
01:57aSANOFI : données positives en cancer du poumon
09/20SANOFI : Une présentation de dernière minute au congrès de l'ESMO montre qu'une ..
Analyst Recommendations on SANOFI
08/18SANOFI : UBS remains its Buy rating
MD
08/18SANOFI : Credit Suisse reiterates its Buy rating
MD
08/17SANOFI : Receives a Buy rating from JP Morgan
MD
08/17SANOFI : Goldman Sachs gives a Buy rating
MD
08/03SANOFI : Credit Suisse remains its Buy rating
MD
More recommendations
Press releases
08:25aSANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
GL
08:25aLate-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy incre..
GL
09/20SANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
GL
09/20SANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
AQ
09/20SANOFI : Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy..
AQ
More press releases